DrAid™ - MRI Rectal Cancer D&T
An AI-powered platform that aids radiologists in the early and precise identification of rectal cancer, while also assisting oncologists in treatment planning, including Total Mesorectal Excision Surgery (TME)
introduction
Introducing DrAid™ Rectal Cancer MRI, a groundbreaking AI-powered platform revolutionizing the landscape of rectal cancer diagnosis and treatment
This innovative solution empowers doctors and radiologists to identify rectal cancer with unparalleled accuracy, aiding in early detection and precise intervention. DrAid™ goes beyond diagnosis, providing crucial support to oncologists in crafting effective treatment plans, including the intricate Total Mesorectal Excision Surgery (TME).
KEY Features
• Mesorectal, Rectal, and Lymph Node Segmentation
• Rectal Tumor Segmentation
• Accurate Measurement of Tumor Parameter
•COMING SOON: Evaluation and predictive factors of complete response after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
Product highlights
• Triage the tumors
• On-demand show-and-hide rectal and tumor segmentation
• Helps doctors in locating and staging the tumors
• Automatic report generation and comparison with Generative AI
PUBLICATION
Book a demo
Book a demo now to test premium speed and quality
